PlainRecalls
ModerateClass IITerminated

FDA Drug recall · Reported April 15, 2020

fentaNYL Citrate 50 mcg per mL, (Preservative Free) Injection, For IV use, 1,500 mcg per 30 mL, 30 mL Total Volume, in a 35 mL Monoject Barrel Syringe, PharMEDium Services, LLC 913 N. Davis Avenue Cleveland, MS 38732. NDC 61553-672-44

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Recall #
D-1089-2020
Affected scope
290 units
Initiated
March 16, 2020
Compiled from official public sources by the editorial team.
Verify with FDA Drug →
View my saved recalls

PharMEDium Services, LLC recalled fentaNYL Citrate 50 mcg per mL, (Preservative Free) Injection, For IV use, 1,500 mcg per … - a moderate-severity action.

fentaNYL Citrate 50 mcg per mL, (Preservative Free) Injection, For IV use, 1,500 mcg per … was recalled by PharMEDium Services, LLC in April 15, 2020. Reason: Firm is recalling 46 lots of various products because of a lack of sterility assurance.. Check the official notice for the remedy. Verify recall #D-1089-2020 with the FDA Drug before acting.

The recall

PharMEDium Services, LLC issued this moderate-severity FDA Drug recall-Firm is recalling 46 lots of various products because of a lack of sterility assurance..

Moderate
severity level
290 units
affected scope
Class II
classification
April 15, 2020
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-1089-2020 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-1089-2020) was formally reported on April 15, 2020, with the manufacturer initiating the action on March 16, 2020. It is classified under Moderate severity (Class II), with a current status of Terminated. PharMEDium Services, LLC is listed as the recalling firm, operating out of Dayton, NJ. Federal records list the affected scope as 290 units.

The documented reason for this recall is: Firm is recalling 46 lots of various products because of a lack of sterility assurance. Distribution data in the federal record shows the product reached: Distributed Nationwide in the US. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Drugs & Medications recalls over time

Where this recall sits in its category - 14,287 drugs & medications recalls on record

-50005001,0001,5002,000 2006201220152018202120242026 263
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

290 units

Related Recalls

6

5 from same agency

Product description

fentaNYL Citrate 50 mcg per mL, (Preservative Free) Injection, For IV use, 1,500 mcg per 30 mL, 30 mL Total Volume, in a 35 mL Monoject Barrel Syringe, PharMEDium Services, LLC 913 N. Davis Avenue Cleveland, MS 38732. NDC 61553-672-44

Reason for recall

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Terminated
Recall number D-1089-2020
Date reported April 15, 2020
Date initiated March 16, 2020
Recalling firm PharMEDium Services, LLC
Firm location Dayton, NJ
Affected scope 290 units
Distribution Distributed Nationwide in the US

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

Scale of Impact

290 units units affected - limited or regional distribution scale.

Regional (<10K units) ✓ This recall
Multi-state (10K – 100K units) -
Large-scale (100K – 1M units) -
Massive (≥1M units) -

Bracket cutoffs follow federal recall-disclosure conventions; bar widths scale linearly within each bracket. Source: PlainRecalls analysis of U.S. Food and Drug Administration filings.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-1089-2020) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
fentaNYL Citrate 50 mcg per mL, (Preservative Free) Injection, For IV use, 1,500 mcg per 30 mL, 30 mL Total Volume, in a 35 mL Monoject Barrel Syringe, PharMEDium Services, LLC 913 N. Davis Avenue Cleveland, MS 38732. NDC 61553-672-44. Recalled by PharMEDium Services, LLC. Units affected: 290 units.
Why was this product recalled?
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 15, 2020. Severity: Moderate. Recall number: D-1089-2020.
Where was the recalled product distributed?
Distribution: Distributed Nationwide in the US.
How do I check if my product is affected by a recall?
Check the product description and recall number (D-1089-2020) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →

Browse all Drugs & Medications recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported April 15, 2020. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.